As of 2025-07-14, the Relative Valuation of Kiniksa Pharmaceuticals Ltd (KNSA) is 28.08 USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.09 USD, the upside of Kiniksa Pharmaceuticals Ltd based on Relative Valuation is -0.0%.
The range of the Relative Valuation is 28.08 - 28.08 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -120.9x - -120.9x | -120.9x |
| Fair Price | 28.08 - 28.08 | 28.08 |
| Upside | -0.0% - -0.0% | -0.0% |
| Date | P/E |
| 2025-07-11 | -120.93 |
| 2025-07-10 | -124.63 |
| 2025-07-09 | -123.98 |
| 2025-07-08 | -117.14 |
| 2025-07-07 | -120.33 |
| 2025-07-03 | -120.02 |
| 2025-07-02 | -118.13 |
| 2025-07-01 | -117.27 |
| 2025-06-30 | -119.12 |
| 2025-06-27 | -120.71 |
| 2025-06-26 | -122.65 |
| 2025-06-25 | -122.18 |
| 2025-06-24 | -125.10 |
| 2025-06-23 | -123.64 |
| 2025-06-20 | -122.43 |
| 2025-06-18 | -120.24 |
| 2025-06-17 | -120.33 |
| 2025-06-16 | -122.31 |
| 2025-06-13 | -121.83 |
| 2025-06-12 | -119.38 |
| 2025-06-11 | -130.10 |
| 2025-06-10 | -128.16 |
| 2025-06-09 | -130.57 |
| 2025-06-06 | -130.14 |
| 2025-06-05 | -127.08 |
| 2025-06-04 | -124.33 |
| 2025-06-03 | -125.32 |
| 2025-06-02 | -120.20 |
| 2025-05-30 | -117.79 |
| 2025-05-29 | -117.01 |
| 2025-05-28 | -117.35 |
| 2025-05-27 | -114.04 |
| 2025-05-23 | -115.76 |
| 2025-05-22 | -111.72 |
| 2025-05-21 | -112.45 |
| 2025-05-20 | -114.94 |
| 2025-05-19 | -115.12 |
| 2025-05-16 | -113.01 |
| 2025-05-15 | -111.37 |
| 2025-05-14 | -107.75 |
| 2025-05-13 | -110.21 |
| 2025-05-12 | -115.55 |
| 2025-05-09 | -112.06 |
| 2025-05-08 | -115.03 |
| 2025-05-07 | -115.25 |
| 2025-05-06 | -115.98 |
| 2025-05-05 | -119.59 |
| 2025-05-02 | -119.03 |
| 2025-05-01 | -119.42 |
| 2025-04-30 | -116.11 |